Apollo Hospitals Enterprise Ltd.’s profit rose in the March quarter but missed analyst estimates by 29%.
The Chennai-headquartered healthcare group’s net profit rose 60% year-on-year to Rs 145 crore in the fourth quarter, according to its exchange filing. That compares with the Rs 203 crore consensus estimate of analysts tracked by Bloomberg.
- Apollo Hospitals Q4 FY23 Highlights (YoY)
- Revenue rose 21% to Rs 4,302 crore, as compared with an estimate of Rs 4,316 crore.
- Ebitda up 5% to Rs 488 crore, against the Rs 514 crore forecast.
Margin contracted to 11.3% from 13.1%. Analysts had projected it at 11.9%.
The hospital segment registered 51% year-on-year growth in operating profit to Rs 411 crore. The digital health and pharmacy businesses reported a segmental loss of Rs 84 crore, as against a Rs 8 crore profit over the same period last year. The clinic/retail health and diagnostic segment saw a 74% decline in operating profit this quarter as compared to last year.
Shares of Apollo Hospitals closed 1.1% lower after the results were announced on Tuesday, as compared with a flat benchmark Sensex. BQ Prime